Immune-Privileged Site Targeting

Definition

Choosing disease targets located in body regions with limited immune access, such as the retina, so that viral-vector therapies provoke less immune response.

Cast within

No topic-region cast yet — this appears once Immune-Privileged Site Targeting's compiled claims are aligned into a topic region's argument tree.

Claims mentioning Immune-Privileged Site Targeting (1)

Your notes

Loading notes...